Introduction
============

Background
----------

Frailty is a biological syndrome, implying reduced physiological reserves and vulnerability to stressors.[@b1-dhps-9-077],[@b2-dhps-9-077] Frailty is highly associated with functional decline, activity limitations and prolonged recovery for the individual. It also predicts a high risk of being institutionalized and dying within a short time.[@b3-dhps-9-077]--[@b5-dhps-9-077] Frail elderly patients constitute a high percentage of individuals treated in specialized acute care units, and they are characterized by high use of health care resources.[@b6-dhps-9-077],[@b7-dhps-9-077]

Early readmissions of frail elderly patients after an episode of hospital care are common[@b8-dhps-9-077],[@b9-dhps-9-077] and constitute a crucial patient safety outcome and risk predictor. Early rehospitalization rates have been reported to be associated with age, comorbidity, length of hospital stay, polypharmacy, worsening of functional status,[@b10-dhps-9-077] severe morbidities at discharge, preadmis-sion activities of daily living (ADL), malignant disease, dementia, high educational level,[@b11-dhps-9-077] frailty[@b12-dhps-9-077] and discharge from hospital based on patient's own request.[@b13-dhps-9-077] The most frequent diagnosis-related causes are cardiovascular disease and pulmonary disease.[@b14-dhps-9-077] Several risk prediction models for hospital readmission have been described,[@b15-dhps-9-077],[@b16-dhps-9-077] and strategies to reduce readmissions have been outlined.[@b17-dhps-9-077] In a systematic review, however, most such interventions were reported to have limited, if any, effect.[@b18-dhps-9-077]

Adverse drug reactions (ADRs) are defined as "any noxious, unintended, and undesired effect of a drug, excluding therapeutic failures, intentional and accidental poisoning, and drug abuse."[@b19-dhps-9-077] Causality assessment scales have been widely used to determine the likelihood that an individual patient's condition indeed is an ADR, i.e., that a drug caused the undesirable condition.[@b20-dhps-9-077],[@b21-dhps-9-077] There are also sets of criteria to assess the avoidability of an identified ADR.[@b22-dhps-9-077] Despite the presence of these scales, it can be very difficult to decide whether an adverse clinical event is really an ADR or due to worsening of the patient's disease.[@b23-dhps-9-077],[@b24-dhps-9-077]

Of all hospital admissions in older patients, several studies have reported 6--12% to be due to ADRs.[@b23-dhps-9-077],[@b25-dhps-9-077]--[@b27-dhps-9-077] However, in a recent large study, 3.3% of admissions of patients aged 65 years or older were reported to be ADR related,[@b28-dhps-9-077] while in another study it was 18%.[@b29-dhps-9-077] Some ADR-related hospitalizations are unavoidable, but a substantial proportion of hospital admissions for ADRs has been judged to be avoidable,[@b29-dhps-9-077]--[@b31-dhps-9-077] including ADRs due to missed contraindications, improper dosage, foreseeable drug interactions or reexposure of patients who have known drug allergies or other medication errors.[@b32-dhps-9-077] The main risk factors for ADR-related hospitalizations in older patients have been identified as advanced age, many drugs, multimorbidity and potentially inappropriate medications.[@b23-dhps-9-077],[@b33-dhps-9-077]

ADRs are more frequently identified in frail elderly patients than in younger patients,[@b34-dhps-9-077],[@b35-dhps-9-077] and they are more likely to cause hospitalizations.[@b36-dhps-9-077] This is attributed to somatic age-related changes in the metabolism, i.e., the capacity of elimination of drugs, polypharmacy and morbidity implying an increased vulnerability in various organs. ADR risk also increases with a larger comorbidity burden, inappropriate prescribing and suboptimal monitoring of drugs.[@b37-dhps-9-077] The drugs that most frequently are reported to have caused an ADR are cardiovascular drugs, drugs with central nervous effects, anticoagulants and nonsteroidal anti-inflammatory drugs (NSAIDs). The most common clinical manifestations are falls, orthostatic hypotension, bleeding, delirium and renal failure.[@b37-dhps-9-077]

It has been pointed out that polypharmacy might be appropriate in some clinical contexts.[@b28-dhps-9-077],[@b38-dhps-9-077] Most studies have focused on overuse, or inappropriate use of drug treatments. However, the opposite can also be of significant importance. In one study, 13% of hospital admissions were assessed to be medication related, and including also underuse of evidence-based regimens.[@b39-dhps-9-077] Of these admissions, 20% were classified as preventable. Underuse of drugs in an elderly care context has been reported, even when there is reasonable evidence for beneficial effects also for elders, e.g., regarding anticoagulants in atrial fibrillation,[@b40-dhps-9-077],[@b41-dhps-9-077] Angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and beta-blockers in heart failure[@b42-dhps-9-077],[@b43-dhps-9-077] and anti-dementia drugs.[@b44-dhps-9-077] Focusing on avoiding ADRs might lead to reductions in the potential benefits of drug therapy.[@b45-dhps-9-077]

Importance
----------

Early rehospitalizations of frail elderly patients are common and constitute a problem for the individual patient as well as for the health care system from a socioeconomic perspective. Polypharmacy is common for these patients, and ADRs have been pointed out as an important cause of admissions. However, there are also data indicating that underuse of evidence-based drug treatments in the elderly might be common even when clearly indicated. From a patient safety perspective, it is important to give a balanced description of the causes of early readmissions of frail elderly patients, including the role of medications.

Goals of the investigation
--------------------------

Our aim was to study the causes of early rehospitalizations of frail elderly patients, particularly in the context of medications, including both over- and underuse of evidence-based treatments.

Patients and methods
====================

Study design and setting
------------------------

This is a clinical, prospective, observational study. It was carried out at the NU County Hospital Group in the Västra Götaland region in Sweden between March 2013 and July 2015 within the study entitled "Is the treatment of frail elderly patients effective in an elderly care unit (TREEE)." The TREEE study was approved by the independent ethics committee at the Sahlgrenska University Hospital in Gothenburg, Sweden (8883-12, 20121212) and registered at the Swedish National Database of Research and Development; identifier 113021 (<http://www.researchweb.org/is/vgr/project/113021>; November 4, 2012).

Selection of participants
-------------------------

The selection of participants and primary data collection has been previously described.[@b46-dhps-9-077] In summary, a total of 419 patients were included, 408 of whom could be evaluated. Inclusion criteria were as follows: age ≥75 years, screened as frail according to the validated FRail Elderly Support ResearcH (FRESH) group screening instrument[@b47-dhps-9-077] and assessed as being in need of inpatient care. Two or more of the following criteria in the FRESH screening instrument implied frailty: tiredness from a short walk, general fatigue, frequent falls/anticipation of falls, dependence in shopping and three or more visits to the emergency ward during the past 12 months. Exclusion criteria included patients in acute need of care at an organ-specific medical unit, e.g., patients with an acute myocardial infarction or a strong suspicion of stroke. During the index care episode, 18 out of the 408 patients died before discharge. Thus, 390 patients who were discharged alive could be studied regarding early rehospitalizations and their causes ([Figure 1](#f1-dhps-9-077){ref-type="fig"}). All patients provided written informed consent to participate.

Methods and measurements
------------------------

### Clinical characteristics, hospital care consumption, rehospitalizations and mortality

The following data were collected from patients, medical records and registers during the index care episode and at the 3-month follow-up visit: age, gender, housing, diabetes mellitus, renal function, heart failure, other comorbidities, number of inhospital care days, rehospitalizations and mortality. ADL independence/dependence was assessed by using the ADL staircase before discharge.[@b48-dhps-9-077] The patient's total burden of morbidity was measured by the Charlson Comorbidity Index.[@b49-dhps-9-077] The degree of frailty was determined using the FRESH screening instrument.[@b47-dhps-9-077] The risk of malnutrition was assessed by the Mini Nutritional Assessment -- short form (MNA-SF).[@b50-dhps-9-077] Polypharmacy was defined as 10 or more drugs in one patient.

### Classification and characteristics of early rehospitalizations

Early rehospitalization was defined as occurring within 30 days from index hospitalization discharge. Classification of cause and characteristics of early rehospitalizations were made retrospectively from medical records by clinical judgment and through scoring scales. Two senior clinicians independently classified the early rehospitalization cases into one of three categories based on the most probable main cause: 1) probably due to ADR according to clinical judgment and/or Naranjo scoring; 2) probably due to underuse of evidence-based drug treatment according to clinical judgment; and 3) probably not due to ADRs or underuse of evidence-based drug treatment. When the clinical judgment was discordant, a third clinician performed a final judgment.

The classification included the Naranjo score to identify an ADR as the cause of the condition.[@b20-dhps-9-077],[@b21-dhps-9-077] A condition was classified as ADR if deemed probable or definite, i.e., if the Naranjo score was \>4. Similarly probable avoidability of the rehospitalization was assessed by clinical judgment and, when an ADR was identified, the Hallas criteria.[@b22-dhps-9-077] If the Hallas criteria pointed out the ADR to be definitely avoidable, it was deemed to be avoidable in our study.

Early rehospitalization was classified as due to underuse of drug treatment when the absence of evidence-based treatment constituted the probable cause of the rehospitalization, and the indication was known at discharge and there was no absolute or relative contraindication.

Statistical analysis
--------------------

The data were computerized and analyzed using the SPSS Statistics for Windows, Version 22.0 (IBM Corporation, Armonk, NY, USA). Descriptive data are presented as mean, one SD and median (range). The Student's *t*-test was used to calculate the 95% CI of the mean. Categorical data were analyzed using Fisher's exact test or the *χ*^2^ test, and the continuous data were compared using Student's *t*-test. When there was a significant difference, the Bonferroni post hoc test was used. A *p*-value of ≤0.05 was considered statistically significant. Regarding adjusted analysis of factors predicting early rehospitalizations, a logistic regression model was used.

Results
=======

Characteristics of study subjects
---------------------------------

Of 390 evaluable patients discharged from the index care episode, 96 patients (24.6%) were rehospitalized within 30 days, while 294 patients were not (75.4%). Baseline characteristics of both groups are presented in [Table 1](#t1-dhps-9-077){ref-type="table"}. In unadjusted analysis, the groups did not differ significantly in terms of age, gender, total morbidity burden, living in residential care, own living with home help services, marital status, ADL, MNA, frailty score, duration of index hospital stay and most of the studied diagnoses (all *p* \> 0.05). These data also indicate that disabilities, i.e., dependence or difficulty carrying out personal or instrumental ADL, were common among the participants in both groups. Both groups were heavily affected by diseases, particularly cardiovascular disease. The exceptions were that the early rehospitalized participants had a significantly higher baseline prevalence of chronic heart failure (*p* = 0.017), ane-mia (*p* = 0.001) and a higher prevalence of polypharmacy (*p* \< 0.001). By logistic regression analysis, independent predictors for early rehospitalization were anemia (*p* = 0.0031) and chronic heart failure (*p* = 0.024), and none of the other baseline variables (*p* \> 0.05).

Main results
------------

Admission characteristics of early rehospitalized patients are presented in [Table 2](#t2-dhps-9-077){ref-type="table"}. The symptoms and conditions which most frequently caused readmissions were dyspnea (n = 25), worsened general condition/tiredness (n = 18), pain (n = 15), suspected infection (n = 14) and vertigo/falling (n = 10). The admission route was the ambulance for all these patients (n = 96). The four most frequent primary diagnoses at the index care episode for these patients in need of rehospitalization were pneumonia/exacerbation of chronic obstructive pulmonary disease (COPD)/acute bronchitis (n = 21), heart failure (n = 19), urinary tract infection (n = 11) and other infectious disease (n = 9). The four most frequent primary diagnoses at the early rehospitalization episode were heart failure (n = 17), pneumonia/exacerbation of COPD/acute bronchitis (n = 13), other infectious disease (n = 10) and urinary tract infection (n = 8).

Early rehospitalizations probably due to ADRs according to clinical judgment and/or Naranjo scoring (n = 13) are presented in [Table 3](#t3-dhps-9-077){ref-type="table"}. The number of ADRs according to clinical judgment was 13, and according to the Naranjo score was 9. The nine patients with ADRs according to the Naranjo score were included in the 13 clinical judgment patients. Of these early rehospitalizations probably due to an ADR, two were classified as probably avoidable by clinical assessment. The same two patients were classified as probably avoidable by the Hallas score. None of these 13 patients died.

Early rehospitalizations identified through clinical judgment as probably due to underuse of evidence-based drug treatment, i.e., despite known indication at the index care episode and without known contraindication (n = 19), are presented in [Table 4](#t4-dhps-9-077){ref-type="table"}. The most frequently identified indications, not treated with evidence-based drug treatment, were heart failure (n = 11) and atrial fibrillation (n = 3). Of these 19 early rehospitalizations probably due to underuse of evidence-based drug treatment, all were classified as probably avoidable by clinical assessment. None of these 19 patients died.

Early rehospitalizations identified through clinical judgment as probably not due to ADRs or underuse of evidence-based drug treatment (n = 64) are presented in [Table S1](#SD1-dhps-9-077){ref-type="supplementary-material"}. None of these rehospitalizations were assessed as probably avoidable. Of these patients, eight died during the rehospitalization.

Regarding the comparison of the proportions of patients rehospitalized due to underuse of evidence-based drug treatment (19/96) and patients rehospitalized due to ADRs (13/96), there was no statistically significant difference (*p* = 0.333). Regarding the comparison of the proportions of patients rehospitalized due to underuse of evidence-based drug treatment, assessed to be avoidable (19/96), and patients rehospitalized due to ADRs, assessed to be avoidable (2/96), there was a statistically significant difference (*p* \< 0.0001).

Discussion
==========

In this study, one out of four frail elderly patients was rehospitalized within 1 month after discharge from a hospitalization episode. The most frequently reported symptoms causing rehospitalization were dyspnea and tiredness, and the most frequently reported diagnoses were heart failure and infectious disease. Independent risk predictors for rehospitalization were heart failure and anemia at index hospitalization discharge.

ADRs were reported to be the main cause in 13 of the 96 (13.5%) rehospitalizations when assessment was performed through clinical judgment, and in nine of the 96 (9.4%) rehospitalizations when the Naranjo scale was used. In two of the 96 (2.1%) rehospitalizations, avoidable ADRs were assessed to be the main cause, according to clinical judgment as well as according to the Hallas avoidability criteria. The drugs most frequently reported to have caused an ADR were warfarin, digoxin and antidepressants. The most common clinical manifestations were bleeding, gastrointestinal symptoms and falls.

Underuse of evidence-based drug treatment, i.e., no treatment at discharge despite the known presence of an indication and the absence of contraindication, was assessed through clinical retrospective judgment to be the main probable cause of rehospitalization in 19 of the 96 (19.8%) patients. All of these undertreatment cases were assessed as potentially avoidable. The diagnoses most frequently associated with underuse of evidence-based drug treatment were heart failure and atrial fibrillation. The drugs that consequently most frequently were reported to be underused were ACE inhibitors/ARBs, beta-blockers and anticoagulants.

The rate of early rehospitalizations in this study is higher compared to most previous reports.[@b8-dhps-9-077],[@b9-dhps-9-077] This is most probably due to the characteristics of our study population including high age, multimorbidity and frailty, which are all considered to predict rehospitalizations.

ADRs constituted the probable main cause of readmission for 9.4--13.5% of the patients, which resembles the percentages reported in previous studies.[@b23-dhps-9-077] Only two avoidable ADRs as main cause of readmission were identified, i.e., 15.4% (2/13) up to 22.2% (2/9) of all ADRs causing rehospitalizations. This proportion is lower than reported in some previous studies,[@b30-dhps-9-077],[@b31-dhps-9-077] although similar to the percentage avoidable ADRs reported in a recent study.[@b29-dhps-9-077] Furthermore, extrapolating this proportion of rehospitalizations due to avoidable ADRs to a clinical population of frail elderly would imply that many patients are affected.

Underuse of evidence-based drug treatment was assessed to be the main probable cause in as much as 19.8% of rehospitalizations in our study, and all of these were assessed to be potentially avoidable. This was based on the presumption that the symptoms causing rehospitalizations, e.g., dyspnea from heart failure, might have been prevented or delayed by evidence-based drug therapy. This estimate might even be conservative, since in cases of a relative, rather than an absolute, contraindication we did not classify the rehospitalization as due to underuse of drug treatment. To our knowledge, very few trials have studied early rehospitalizations from this viewpoint. However, in one study, 13% of hospital admissions were assessed to be medication related including underuse of evidence-based regimens. Of these admissions, 20% were classified as preventable.[@b39-dhps-9-077]

Evidence-based use of drugs has a definite potential to benefit also elderly patients, in some cases even more than in younger patients, since the disease-related risk usually is higher. Despite that the majority of publications focus on drug overuse in the elderly, there are also indications of underuse of drugs, even when there is reasonable evidence for beneficial effects also for elders, e.g., regarding atrial fibrillation (anticoagulants) and heart failure (ACE inhibitors/ARBs and beta-blockers). Powerful efforts to avoid all possible ADRs might switch the benefit--risk balance and lead to suboptimal use of evidence-based drug therapy.[@b45-dhps-9-077]

It is a strength that our study included very frail elderly patients with a heavy comorbidity burden, while these patients would be excluded in most clinical trials. Further, most previous trials studying rehospitalizations of elderly have focused on ADRs, while our aim to describe both ADRs and underuse of drugs, i.e., a balanced perspective, comes closer to the considerations and trade-offs which have to be made in the daily clinical work. Moreover, it is a strength that we combined clinical assessment of ADRs and underuse of drugs with the use of two of the most common assessment scales, including judgment of the avoidability.

One limitation of the study is that it is based on secondary analyses, although in fact outlined in the original study protocol. Further, although the clinical assessments were made in an assessor-blinded fashion, the filling up of the assessment scales was not blinded. On the other hand, the latter assessments did not differ markedly from the former ones, which points to a limited risk of bias. The study sample was mid-sized, and a larger number of patients would have strengthened the results. Further, an even broader approach regarding drug therapy could be valuable in future research.[@b51-dhps-9-077]--[@b53-dhps-9-077] We were not able to specifically investigate the effects of possible drug interactions in this study population. Thus, we cannot exclude the possibility that such interactions could have been involved in a few of the reported rehospitalizations.

Powerful patient safety efforts to avoid ADRs might lead to underestimation of the potential benefits of evidence-based drug therapy. This might have negative consequences for the elderly patients, and for the health care system as well. There is a need for larger studies of frail elderly patients, including evaluating rehospitalizations, which take both the perspective of underuse of drugs and ADRs into account.

Conclusion
==========

In this study, one out of four frail elderly patients discharged from hospital were rehospitalized within 1 month. Independent risk predictors for rehospitalization were heart failure and anemia. Although ADRs constituted an important cause of rehospitalizations, assessed underuse of evidence-based drug treatment might be an even more frequent cause. Moreover, potentially avoidable rehospitalizations were more frequently associated with underuse of evidence-based drug treatment than with ADRs, although this finding should be interpreted with caution, since the number of avoidable ADR readmissions was small in this study. Reasonable patient safety efforts made to avoid ADRs in frail elderly patients must be balanced and combined with evidence-based drug therapy which can benefit these patients. This implies a need for intensified educational efforts regarding drug therapy for frail elderly patients.

Supplementary material
======================

###### 

Early rehospitalizations probably not due to ADRs or underuse of evidence-based drug treatment

  Case   Primary diagnosis at index discharge   Main reported cause of rehospitalization   Primary diagnosis at discharge from rehospitalization   Probably avoidable rehospitalization   Death at rehospitalization
  ------ -------------------------------------- ------------------------------------------ ------------------------------------------------------- -------------------------------------- ----------------------------
  1      COPD with exacerbation                 Dyspnea                                    COPD with exacerbation                                  No                                     No
  2      Stroke                                 Dyspnea                                    Bronchitis                                              No                                     No
  3      Septicemia                             Dyspnea                                    Septicemia                                              No                                     No
  4      Septicemia                             Wound                                      Orthopedic care                                         No                                     No
  5      Wound infection                        Paresis                                    Cerebral infarction                                     No                                     Yes
  6      Septicemia                             Tiredness                                  Endocarditis                                            No                                     No
  7      Pneumonia                              Coughing                                   Pneumonia                                               No                                     No
  8      Atrial fibrillation                    Nausea                                     Atrial fibrillation                                     No                                     No
  9      Myocardial infarction                  Dyspnea                                    Heart failure                                           No                                     No
  10     Nausea                                 Swollen urogenital organ                   Paraphimosis                                            No                                     No
  11     Atrial fibrillation                    Dyspnea                                    Dyspnea                                                 No                                     No
  12     Urinary tract infection                Worsened general condition                 Urinary tract infection                                 No                                     No
  13     Urinary tract infection                Abdominal and back pain                    Vertebral compression                                   No                                     No
  14     Urinary tract infection                Falling                                    Tibia fracture                                          No                                     No
  15     Heart failure                          Dyspnea                                    Septicemia                                              No                                     Yes
  16     Pain                                   Foot pain                                  Foot distorsion                                         No                                     No
  17     Pneumonia                              Fever                                      Pneumonia                                               No                                     No
  18     Anemia                                 Tiredness                                  Calici infection                                        No                                     No
  19     Nausea                                 Malnutrition                               Hiatus hernia                                           No                                     No
  20     Pneumonia                              Dyspnea                                    Pneumonia                                               No                                     No
  21     Heart failure                          Chest pain                                 Cholecystitis                                           No                                     No
  22     Anemia                                 Fainting                                   Pulmonary edema                                         No                                     Yes
  23     Coughing                               Headache                                   Blood pressure fall                                     No                                     No
  24     Myocardial infarction                  Chest pain                                 Myocardial infarction                                   No                                     No
  25     Pulmonary hypertension                 Heart failure                              Heart failure                                           No                                     No
  26     Pneumonia                              Coughing                                   Urinary tract infection                                 No                                     No
  27     Vertebral compression                  Dysarthria                                 Cerebral infarction                                     No                                     No
  28     Anemia                                 Worsened general condition                 Septicemia                                              No                                     No
  29     Septicemia                             Tiredness                                  Urinary tract infection                                 No                                     No
  30     Urinary tract infection                Hip fracture                               Hip fracture                                            No                                     No
  31     Endocarditis                           Absence attack                             Urinary tract infection                                 No                                     No
  32     Anemia                                 Tiredness                                  Anemia                                                  No                                     No
  33     Heart failure                          Tiredness                                  Heart failure                                           No                                     No
  34     Heart failure                          Falling                                    Heart failure                                           No                                     Yes
  35     Headache                               Atrial fibrillation                        Atrial fibrillation                                     No                                     No
  36     Heart failure                          Fever                                      Diverticulitis                                          No                                     No
  37     Pneumonia                              Tiredness                                  Urinary bladder cancer                                  No                                     No
  38     Dermal infection                       Suspected infection                        Dermal infection                                        No                                     No
  39     Heart failure                          Heart failure                              ACE/ARB                                                 Dyspnea                                Heart failure
  40     Pulmonary embolism                     Abdominal pain                             Pleural effusion                                        No                                     No
  41     Vertigo                                Worsened general condition                 Vertigo                                                 No                                     No
  42     COPD with exacerbation                 Dyspnea                                    COPD with exacerbation                                  No                                     No
  43     Myocardial infarction                  Paresis                                    Cerebral infarction                                     No                                     No
  44     Heart failure                          Chest pain                                 Angina pectoris                                         No                                     No
  45     Erysipelas                             Leg ulcers                                 Peripheral arterial insufficiency                       No                                     No
  46     Vertigo                                Vertigo                                    Vertigo                                                 No                                     No
  47     Pneumonia                              Coughing                                   Tiredness                                               No                                     No
  48     Pneumonia                              Dyspnea                                    Pulmonary embolism                                      No                                     No
  49     Hip fracture                           Abdominal pain                             Ileus                                                   No                                     No
  50     COPD with exacerbation                 Dyspnea                                    COPD with exacerbation                                  No                                     Yes
  51     Urinary tract infection                Fever                                      Urinary tract infection                                 No                                     Yes
  52     Pneumonia                              Hand pain                                  Pneumonia                                               No                                     No
  53     COPD, exacerbation                     COPD, exacerbation                         Antibiotics                                             Cough, dyspnea                         COPD, exacerbation
  54     COPD with exacerbation                 Dyspnea                                    Heart failure                                           No                                     No
  55     Pneumonia                              Coughing                                   Pneumonia                                               No                                     Yes
  56     Heart failure                          Worsened general condition                 Pneumonia                                               No                                     No
  57     Cholecyctitis                          Hip pain                                   Hip fracture                                            No                                     No
  58     Heart failure                          Cardiac arrest                             Cardiac arrest                                          No                                     Yes
  59     Atrial fibrillation                    Chest pain                                 Chest pain                                              No                                     No
  60     Vertebral compression                  Bleeding                                   Vertebral fracture                                      No                                     No
  61     Urinary tract infection                Fever                                      Utero-vaginal prolapsis                                 No                                     No
  62     Orthostatism                           Falling                                    Encephalopatia                                          No                                     No
  63     Pleural effusion                       Dyspnea                                    Dyspnea                                                 No                                     No
  64     Chest pain                             Chest pain                                 Angina pectoris                                         No                                     No

**Abbreviations:** ADR, adverse drug reaction; COPD, chronic obstructive pulmonary disease.

This study was funded by grants from the Healthcare Subcommittee, Region Västra Götaland; Department of Research and Development, NU Hospital Group and the Fyrbodal Research and Development Council, Region Västra Götaland, Sweden. We acknowledge Göran Östberg and Maria Johansson for valuable discussions regarding clinical judgments in the study.
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###### 

Baseline (index care episode) clinical and demographic characteristics of early readmitted patients (n=96) and patients not readmitted early (n=294), unadjusted analysis

  Characteristics                                                      Readmitted early (n = 96)   Not readmitted early (n = 294)   *p*-value
  -------------------------------------------------------------------- --------------------------- -------------------------------- -----------
  Age, mean (years) (SD)                                               85.7 (5.1)                  85.7 (5.5)                       0.960
  Gender, male, n (%)                                                  47 (49.0)                   122 (41.5)                       0.236
  Charlson score, mean (SD)                                            6.8 (1.8)                   6.8 (1.9)                        0.984
  ADL score, mean (SD)                                                 4.9 (2.2)                   4.4 (2.6)                        0.064
  Frailty score, mean (SD)                                             3.5 (0.95)                  3.4 (0.84)                       0.350
  MNA, mean (SD)                                                       10.2 (2.4)                  10.2 (2.6)                       0.968
  Residential care,[\*](#tfn1-dhps-9-077){ref-type="table-fn"} n (%)   11 (11.5)                   37 (12.6)                        0.859
  Own living with home help services, n (%)                            38 (60.4)                   146 (49.7)                       0.078
  Married/living in partnership, n (%)                                 26 (27.1)                   105 (35.7)                       0.136
  Ischemic heart disease, n (%)                                        26 (27.0)                   91 (31.0)                        0.523
  Chronic heart failure, n (%)                                         48 (50.0)                   106 (36.1)                       0.017
  COPD, n (%)                                                          18 (18.8)                   57 (19.4)                        1.000
  Tumor, n (%)                                                         12 (12.9)                   52 (17.7)                        0.269
  Dementia, n (%)                                                      7 (7.3)                     37 (12.6)                        0.194
  Anemia, n (%)                                                        64 (66.7)                   138 (46.9)                       0.001
  Diabetes, n (%)                                                      20 (20.8)                   48 (16.3)                        0.353
  Renal function, GFR                                                  38.9                        53.1                             0.155
  Index diagnosis: acute heart failure, n (%)                          37 (38.5)                   85 (28.9)                        0.077
  Index diagnosis: bacterial infection, n (%)                          46 (47.9)                   129 (43.9)                       0.555
  Index diagnosis: myocardial infarction, n (%)                        6 (6.2)                     12 (4.1)                         0.403
  Reported cases with 10 or more drugs, n (%)                          60 (62.5)                   159 (54.0)                       \<0.001
  LOS index, days, mean, n (SD)                                        10.5 (7.8)                  10.0 (6.0)                       0.552

**Note:**

Living in care facilities.

**Abbreviations:** ADL, activities of daily living; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; LOS, length of stay; MNA, Mini Nutritional Assessment.

###### 

Admission characteristics of early readmissions (n = 96)

  Characteristics                                N
  ---------------------------------------------- ----
  Primary diagnosis at index hospitalization     
   Pneumonia/exacerbation/acute bronchitis       21
   Heart failure                                 19
   Urinary tract infection                       11
   Other infectious disease                      9
   Pain                                          5
   Arrhythmia                                    5
   Acute coronary syndrome                       5
   Vertigo                                       4
   Anemia                                        4
   Others                                        13
  Cause of readmission, condition                
   Dyspnea                                       25
   Worsened general condition/tiredness          18
   Pain                                          15
   Fever/infection                               14
   Vertigo/falling                               10
   Others                                        14
  Primary diagnosis at early rehospitalization   
   Heart failure                                 17
   Pneumonia/exacerbation/acute bronchitis       13
   Other infectious disease                      10
   Urinary tract infection                       8
   Stroke/TIA                                    7
   Fracture                                      7
   Arrhythmia                                    5
   Myocardial infarction/angina pectoris         3
   Pain                                          3
   Bleeding/anemia                               3
   Others                                        20

**Abbreviation:** TIA, transient ischemic attack.

###### 

Early rehospitalizations probably due to ADRs according to clinical judgment and/or Naranjo scoring[§](#tfn4-dhps-9-077){ref-type="table-fn"}

  Case   Primary diagnosis at index discharge   Main reported cause of rehospitalization   Primary diagnosis at discharge from rehospitalization   ADR, clinical judgment[\*](#tfn5-dhps-9-077){ref-type="table-fn"}   ADR, Naranjo score[\*\*](#tfn6-dhps-9-077){ref-type="table-fn"}   Probably avoidable rehospitalization, clinical judgment   Probably avoidable rehospitalization, Hallas score   Drug/drug class
  ------ -------------------------------------- ------------------------------------------ ------------------------------------------------------- ------------------------------------------------------------------- ----------------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------------------------
  1      Back pain                              Constipation                               Constipation                                            Yes                                                                 Yes, 5                                                            No                                                        No                                                   Oxycodon/opioid
  2      Heart failure                          Constipation                               Abdominal pain                                          Yes                                                                 Yes, 5                                                            No                                                        No                                                   Citalopram/antidepressant
  3      Urinary tract infection                Falling                                    Falling                                                 Yes                                                                 No, 3                                                             No                                                        No                                                   Carbamazepine/antiepileptic
  4      Orthostatism                           Fainting                                   Orthostatism                                            Yes                                                                 Yes, 6                                                            No                                                        No                                                   Metoprolol/beta-blocker
  5      Depression                             Falling                                    Fracture (collum chirurgicum)                           Yes                                                                 No, 4                                                             No                                                        No                                                   Duloxetine/antidepressant
  6      Heart failure                          GI bleeding                                GI bleeding                                             Yes                                                                 Yes, 6                                                            No                                                        No                                                   Warfarin/anticoagulant
  7      Heart failure                          Falling                                    Hip pain                                                Yes                                                                 Yes, 5                                                            Yes                                                       Yes                                                  Digoxin/digitalis glycoside
  8      NSTEMI                                 GI bleeding                                Enterocolitis                                           Yes                                                                 Yes, 5                                                            No                                                        No                                                   ASA/salicylate + clopidogrel/P2Y12 inhibitor
  9      Supraventricular tachycardia           Vertigo, palpitations                      Supraventricular tachycardia                            Yes                                                                 Yes, 5                                                            No                                                        No                                                   Metoprolol/beta-blocker + felodipine/calcium channel blocker
  10     Heart failure                          Fever, diarrhea                            Enterocolitis                                           Yes                                                                 Yes, 5                                                            No                                                        No                                                   Clindamycin/macrolide
  11     Pneumonia                              Abdominal pain                             Muscle hemorrhage                                       Yes                                                                 No, 3                                                             No                                                        No                                                   Warfarin/anticoagulant
  12     Heart failure                          Nausea, tiredness                          Renal cancer                                            Yes                                                                 Yes, 6                                                            Yes                                                       Yes                                                  Digoxin/digitalis glycoside
  13     Bronchitis                             Tiredness                                  Urinary tract infection                                 Yes                                                                 No, 1                                                             No                                                        No                                                   Furosemide/loopdiuretic + spironolactone/potassium-sparing diuretic
                                                                                                                                                   13                                                                  9                                                                 2                                                         2                                                    

**Notes:**

Thirteen early rehospitalizations were classified as probably due to ADRs by clinical judgment and/or the Naranjo score. Among these cases, two rehospitalizations were classified as probably avoidable by clinical judgment and/or the Hallas score.

Classified as probable ADR by two independent clinicians (Björn W Karlson and Göran Östberg). When the judgment was discordant, a third clinician (Niklas Ekerstad) performed judgment (case 6).

ADR classified as probable according to the Naranjo score, i.e., \>4. The figures denote Naranjo score. None of these patients died during the rehospitalization care episode.

**Abbreviations:** ADR, adverse drug reaction; ASA, acetylsalicylic acid; GI, gastrointestinal; NSTEMI, non ST elevation myocardial infarction.

###### 

Early rehospitalization probably due to drug underuse, according to clinical judgment[§](#tfn8-dhps-9-077){ref-type="table-fn"}

  Case   Primary diagnosis at index discharge   Indication for drug treatment known at index care episode   Absence of treatment at discharge from index -- drug class[\*](#tfn9-dhps-9-077){ref-type="table-fn"}   Main reported cause of rehospitalization   Primary diagnosis at discharge from rehospitalization
  ------ -------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------ -------------------------------------------------------
  1      Pneumonia                              Pneumonia                                                   Antibiotics                                                                                             Dyspnea, cough                             Pneumonia
  2      Heart failure                          Atrial fibrillation, CHADS-VASC 5                           Anticoagulant                                                                                           Paresis                                    TIA
  3      Heart failure                          Known previous stroke                                       ASA                                                                                                     Stroke                                     Cerebral infarction
  4      COPD with exacerbation                 Heart failure                                               Beta-blocker                                                                                            Worsened general condition                 Worsened general condition
  5      Heart failure                          Heart failure                                               ACE/ARB                                                                                                 Dyspnea                                    Heart failure
  6      Urinary tract infection                Heart failure                                               Beta-blocker                                                                                            Dyspnea                                    Heart failure
  7      Unstable angina                        Unstable angina                                             DAPT                                                                                                    Progressive chest pain                     Chest pain
  8      Abnormal ADH sekretion                 Heart failure                                               Beta-blocker                                                                                            Dyspnea                                    Heart failure
  9      Malnutrition                           Heart failure                                               ACE/ARB                                                                                                 Dyspnea, back pain                         Heart failure
  10     Sick sinus syndrome                    Heart failure                                               ACE/ARB                                                                                                 Dyspnea                                    Heart failure
  11     Pyelonefritis                          Heart failure                                               ACE/ARB; beta-blocker                                                                                   Tiredness                                  Worsened general condition
  12     Enterocolitis (*C. difficile*)         Enterocolitis (*C. difficile*)                              Antibiotics                                                                                             Diarrhea                                   Enterocolitis (*C. difficile*)
  13     Pneumonia                              Atrial fibrillation. CHADS-VASC                             Anticoagulants                                                                                          Paresis, aphasia                           Cerebral infarction
  14     Asthma                                 Heart failure                                               ACE/ARB                                                                                                 Dyspnea                                    Dyspnea
  15     Heart failure                          Heart failure                                               Beta-blocker                                                                                            Dyspnea                                    Heart failure
  16     COPD, exacerbation                     Heart failure                                               ACE/ARB                                                                                                 Dyspnea                                    Heart failure
  17     Heart failure                          Heart failure                                               Beta-blocker                                                                                            Tiredness                                  Infection, heart failure
  18     COPD, exacerbation                     COPD, exacerbation                                          Antibiotics                                                                                             Dyspnea                                    COPD, exacerbation
  19     Diverticulitis                         Known paroxysmal atrial fibrillation                        Anticoagulants                                                                                          Dysarthria                                 Stroke

**Notes:**

Early rehospitalization classified as probably due to underuse of evidence-based drug treatment despite known indication at discharge from the index care episode. Classified as probably avoidable rehospitalization by two independent clinicians (Niklas Ekerstad and Björn W Karlson).

Absence of evidence-based treatment constituting the probable cause of rehospitalization. Known indication and no known contraindication. Of these 19 early rehospitalizations probably due to underuse of evidence-based drug treatment, all were classified as probably avoidable by clinical assessment. None of these patients died during the rehospitalization care episode.

**Abbreviations:** ACE/ARB, angiotensin converting enzyme-inhibitor/angiotensin II receptor antagonist; ADH, antidiuretic hormone secretion; ASA, acetylsalicylic acid; *C. difficile*, *Clostridium difficile;* COPD, chronic obstructive pulmonary disease; DAPT, dual antiplatelet therapy; TIA, transient ischemic attack.
